Diagnostic and prognostic markers for human prostate cancer (Q41495930)

1 October 2017

1 reference

title

Diagnostic and prognostic markers for human prostate cancer (English)

1 reference

1 October 2017

Gao X

1 reference

1 October 2017

Porter AT

1 reference

1 October 2017

Grignon DJ

1 reference

1 October 2017

Pontes JE

1 reference

1 October 2017

Honn KV

1 reference

1 October 2017

publication date

1 June 1997

1 reference

1 October 2017

1 reference

1 October 2017

1 reference

1 October 2017

1 reference

1 October 2017

page(s)

264-281

1 reference

Prostate Cancer: Screening, Diagnosis, and Management

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Socioeconomic factors and cancer incidence among blacks and whites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Recessive oncogenes: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Retinoblastoma and p53 genes as prognostic indicators in urological oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Results of conservative management of clinically localized prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Patient-re ported complications and follow-up treatment after radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Human prostatic acid phosphatase: selected properties and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Human prostatic acid phosphatase: cDNA cloning, gene mapping and protein sequence homology with lysosomal acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Structure of human prostatic acid phosphatase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Diagnostic markers of prostate cancer: utility of prostate-specific antigen in diagnosis and staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Human prostate-specific antigen: structural and functional similarity with serine proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Characterization of the prostate-specific antigen gene: a novel human kallikrein-like gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Inhibition of tumorigenic potential and prostate‐specific antigen expression in LNCaP human prostate cancer cell line by 13‐cis‐retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Extraprostatic localization of prostatic acid phosphatase and prostate-specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

False positive prostate specific antigen values in the sera of women with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Assay for prostate specific antigen (PSA): problems and possible solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Western blot assay for prostate-specific membrane antigen in serum of prostate cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Prostate specific antigen in the diagnosis and treatment of adenocarcinoma of the prostate. I. Untreated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Further Experience with the Urethral Kock Pouch

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Detection of prostatic-inhibin-like peptide in the cytoplasm of LNCaP cells, a human prostatic adenocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Generation and characterization of monoclonal antibodies to prostate secretory protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Suppression of DNA synthesis and induction of apoptosis in rat prostate by human seminal plasma inhibin (HSPI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

A novel prostate carcinoma-associated glycoprotein complex (PAC) recognized by monoclonal antibody TURP-27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Ability of preoperative serum prostatespecific antigen value to predict pathologic stage and DNA ploidy Influence of clinical stage and tumor grade

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Serum prostate-specific antigen and the biologic progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Secretion of prostate-specific antigen-suppressing activity by two human prostate carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Measurement of prostate-specific membrane antigen in the serum with a new antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

12(S)-HETE enhancement of prostate tumor cell invasion: selective role of PKC alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

12-Lipoxygenase, 12(S)-HETE, and cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

p53 in prostate cancer: frequent expressed transition mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

p53 gene mutations in human prostate cancers in Japan: different mutation spectra between Japan and western countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Comparative studies of prostate cancers among United States, Chinese, and Japanese patients: characterization of histopathology, tumor angiogenesis, neuroendocrine factors, and p53 protein accumulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

p53 gene alterations in human prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

p53 mutations occur in clinical, but not latent, human prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

p53 Mutations in Benign Prostatic Hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Mutations of two PMS homologues in hereditary nonpolyposis colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Fatty acid synthesis: a potential selective target for antineoplastic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Cellular proliferation in prostatic adenocarcinoma as assessed by bromodeoxyuridine uptake and Ki-67 and PCNA expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Pathological and clinical associations of Ki-67 defined growth fractions in human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Cell proliferation in prostatic adenocarcinoma: in vitro measurement by 5-bromodeoxyuridine incorporation and proliferating cell nuclear antigen expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Relationship of proliferating cell nuclear antigen (PCNA) in prostatic carcinomas to various clinical parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Cadherin cell adhesion receptors as a morphogenetic regulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

The role of cell adhesion molecules in cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

E-cadherin gene mutations in human gastric carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: biological significance and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Biological roles of oligosaccharides: all of the theories are correct

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Neuroendocrine differentiation in human prostatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

High-mobility-group proteins P1, I and Y as substrates of the M-phase-specific p34cdc2/cyclincdc13 kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Serum metalloproteinases and their inhibitors: markers for malignant potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Risk of Cancer in Relatives of Prostate Cancer Probands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Oral Contraceptive-induced Expression of Prostate-specific Antigen in the Female Breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Original Articles: Prostate Cancer: Measurement of Serum Prostate Specific Antigen Levels in Women and in Prostatectomized Men With an Ultrasensitive Immunoassay Technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Detection of prostate-specific antigen immunoreactivity in breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Stage at presentation and survival of white and black patients with prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Immunohistochemistry of prostatic acid phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

What is the 'normal range' for prostate-specific antigen? Use of a receiver operating characteristic curve to evaluate a serum marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Prostate antigen: A new potential marker for prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Regulation of prostate-specific antigen gene expression in LNCaP human prostatic carcinoma cells by growth, dihydrotestosterone, and extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Immunoreactive prostatic specific antigen in male periurethral glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

An Analysis of Urinary Prostate Specific Antigen Before and After Radical Prostatectomy: Evidence for Secretion of Prostate Specific Antigen by the Periurethral Glands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Prostate marker immunoreactivity in salivary gland neoplasms. A rare pitfall in immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

False-positive serum prostate-specific antigen values in a patient with non-Hodgkin lymphoma of the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

An evaluation of prostate specific antigen in prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Relative performance characteristics of prostate specific antigen and prostatic specific antigen density for the diagnosis of carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Serum Prostate Specific Antigen Complexed toα1-Antichymotrypsin as an Indicator of Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Molecular staging of prostate cancer. II. A comparison of the application of an enhanced reverse transcriptase polymerase chain reaction assay for prostate specific antigen versus prostate specific membrane antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Radioimmunoscintigraphy of pelvic lymph nodes with 111indium-labeled monoclonal antibody CYT-356

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Immunohistochemical localization of a prostatic secretory protein of 94 amino acids in normal prostatic tissue, in primary prostatic tumors and in their metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

PR92 antigen in human prostate fluid: elevated levels in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Identification of IgG and Fc-Binding Proteins in Human Seminal Plasma and Sperm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Immunoglobulin binding factor of seminal plasma: a secretory product of human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Immunoglobulin binding factor: a new tumor marker for prostatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Prostate Specific Antigen and Prostatic Acid Phosphatase Immunoreactivity as Prognostic Indicators of Advanced Prostatic Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

The prognostic significance of histological grading and pathological staging in carcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

The Use of Prostate Specific Antigen, Clinical Stage and Gleason Score to Predict Pathological Stage in Men with Localized Prostate Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Detection of circulating tumor cells in men with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Elevated 12-lipoxygenase mRNA expression correlates with advanced stage and poor differentiation of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Mutant p53 expression in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

p53 Protein Accumulation and Gene Mutation in the Progression of Human Prostate Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Tumor suppressor gene p53 mutations in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Prostatic carcinoma: histological and immunohistological factors affecting prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Urinary Tissue Factor Levels in Prostatic Carcinoma: A Potential. Marker of Metastatic Spread ?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

Osteocalcin: is it a useful marker of bone metastasis and response to treatment in advanced prostate cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819970601%2931%3A4%3C264%3A%3AAID-PROS8%3E3.0.CO%3B2-K

10.1002/(SICI)1097-0045(19970601)31:4<264::AID-PROS8>3.0.CO;2-K

21 January 2018

Identifiers

DOI

1 reference

1 October 2017

1 reference